| Literature DB >> 27398166 |
Joaquín Araos1, Leyla Alegría1, Patricio García2, Felipe Damiani1, Pablo Tapia3, Dagoberto Soto1, Tatiana Salomon4, Felipe Rodriguez5, Macarena Amthauer5, Benjamín Erranz6, Gabriel Castro5, Pamela Carreño7, Tania Medina7, Jaime Retamal1, Pablo Cruces8, Guillermo Bugedo1, Alejandro Bruhn1.
Abstract
Extracorporeal membrane oxygenation (ECMO) is increasingly being used to treat severe acute respiratory distress syndrome (ARDS). However, there is limited clinical evidence about how to optimize the technique. Experimental research can provide an alternative to fill the actual knowledge gap. The purpose of the present study was to develop and validate an animal model of acute lung injury (ALI) which resembled severe ARDS, and which could be successfully supported with ECMO. Eighteen pigs were randomly allocated into three groups: sham, ALI, and ALI + ECMO. ALI was induced by a double-hit consisting in repeated saline lavage followed by a 2-hour period of injurious ventilation. All animals were followed up to 24 hours while being ventilated with conventional ventilation (tidal volume 10 ml/kg). The lung injury model resulted in severe hypoxemia, increased airway pressures, pulmonary hypertension, and altered alveolar membrane barrier function, as indicated by an increased protein concentration in bronchoalveolar fluid, and increased wet/dry lung weight ratio. Histologic examination revealed severe diffuse alveolar damage, characteristic of ARDS. Veno-venous ECMO was started at the end of lung injury induction with a flow > 60 ml/kg/min resulting in rapid reversal of hypoxemia and pulmonary hypertension. Mortality was 0, 66.6 and 16.6% in the SHAM, ALI and ALI + ECMO groups, respectively (p < 0.05). This is a novel clinically relevant animal model that can be used to optimize the approach to ECMO and foster translational research in extracorporeal lung support.Entities:
Keywords: ARDS; ECMO; mechanical ventilation
Year: 2016 PMID: 27398166 PMCID: PMC4931177
Source DB: PubMed Journal: Am J Transl Res Impact factor: 4.060